Andrew Davis

Andrew Davis

Corporate Officer/Principal en DYNAVAX TECHNOLOGIES CORPORATION .
40 años
Health Technology
Consumer Services

Perfil

Andrew Davis is currently Director at UTILITY therapeutics Ltd. since 2019 and Chief Business Officer at Dynavax Technologies Corp.
starting in 2024.
Formerly, Mr. Davis was Chairman at VectivBio Holding AG; Director at BioMarck Pharmaceuticals Ltd. from 2020 to 2022; Senior Vice President-Business Development at Ironwood Pharmaceuticals, Inc. in 2021; Senior Vice President-Business Development at Bausch Health US LLC from 2014 to 2016; Vice President-Corporate Development at Bausch Health Cos., Inc.; Chief Business Development Officer at iNova Pharmaceuticals (Pty) Ltd. (South Africa) from 2017 to 2021; and Head-Oncology Business Development at Merck & Co., Inc. from 2016 to 2017.
Education includes undergraduate studies at Boston University.

Cargos activos de Andrew Davis

EmpresasCargoInicio
DYNAVAX TECHNOLOGIES CORPORATION Corporate Officer/Principal 01/11/2024
Director/Miembro de la Junta 01/08/2019

Antiguos cargos conocidos de Andrew Davis.

EmpresasCargoFin
IRONWOOD PHARMACEUTICALS, INC. Corporate Officer/Principal 22/11/2024
Director/Miembro de la Junta 01/10/2022
Corporate Officer/Principal 01/05/2021
MERCK & CO., INC. Corporate Officer/Principal 01/09/2017
Corporate Officer/Principal 01/01/2016
Ver el detalle de la experiencia de Andrew Davis.

Formación de Andrew Davis.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

15

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology